# Paxman

Source: https://onco.cc/companies/paxman/  
OnCo record `paxman` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Paxman is the British maker of the Paxman Scalp Cooling System, a chilled cap worn during chemotherapy to reduce hair loss, cleared in the United States in 2017 and used in cancer centres across the world.

## Summary

Paxman, based in Huddersfield and listed on London's AIM market, developed its refrigerated scalp cooling system from the family's drinks-cooling business after a relative's chemotherapy. The system was cleared by the FDA in 2017 for breast cancer and later for solid tumours, and the company is developing cooling for chemotherapy-induced neuropathy.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Tags: machines-wave2
- HQ: Huddersfield
- Type: devices
- Website: https://paxmanscalpcooling.com/
- Ticker: PAX

## Sources

- Official website: https://paxmanscalpcooling.com/
- Paper: SCALP randomised trial (JAMA 2017): https://doi.org/10.1001/jama.2016.20939

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Scalp cooling (cold caps: DigniCap, Paxman)](https://onco.cc/technologies/scalp-cooling/)

---
JSON: https://onco.cc/api/v1/entities/paxman.json